Top Glove sees demand doubling when vaccines ready by year-end


Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

KUALA LUMPUR: While pharmaceutical companies are gaining momentum on positive COVID-19 vaccination news, Top Glove Corporation Bhd expects demand for examination gloves to double when the vaccines are ready by year-end.

Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Top Glove , Demand , Covid-19 update , Lim Wee Chai

Next In Business News

GEAR-uP needs a transparency tune-up
Genting’s high-stakes double-edged win
Genting unit lodges RM5bil unrated MTN programme with SC
SC gives nod to Sunway Healthcare's Bursa Main Market listing
Evergreen Max unit secures RM50mil short-term credit facility from Bank Islam
Ancom Nylex inks RM76.8mil deal to dispose of 50% stake in new unit formed under restructuring
Ringgit extends gains to close higher as US rate cut expectations stay elevated
Gadang sells Selangor land for RM2.5mil
Stocks rise, dollar wilts as investors strap in for Fed rate cut
Bursa Malaysia ends lower as investors eye US data, BOJ decision

Others Also Read